Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782-Santiago de Compostela, Spain.
Acta Biomater. 2011 Mar;7(3):1019-30. doi: 10.1016/j.actbio.2010.10.003. Epub 2010 Oct 8.
The aim of this work was to develop an innovative supercritical fluid (SCF)-assisted molecular imprinting method to endow commercial soft contact lenses (SCLs) with the ability to load specific drugs and to control their release. This approach seeks to overcome the limitation of the common loading of preformed SCLs by immersion in concentrated drug solutions (only valid for highly water soluble drugs) and of the molecular imprinting methods that require choice of the drug before polymerization and thus to create drug-tailored networks. In particular, we focused on improving the flurbiprofen load/release capacity of daily wear Hilafilcon B commercial SCLs by the use of sequential SCF flurbiprofen impregnation and extraction steps. Supercritical carbon dioxide (scCO2) impregnation assays were performed at 12.0 MPa and 40 °C, while scCO2 extractions were performed at 20.0 MPa and 40 °C. Conventional flurbiprofen sorption and drug removal experiments in aqueous solutions were carried out for comparison purposes. SCF-processed SCLs showed a recognition ability and a higher affinity for flurbiprofen in aqueous solution than for the structurally related ibuprofen and dexamethasone, which suggests the creation of molecularly imprinted cavities driven by both physical (swelling/plasticization) and chemical (carbonyl groups in the network with the C-F group in the drug) interactions. Processing with scCO2 did not alter some of the critical functional properties of SCLs (glass transition temperature, transmittance, oxygen permeability, contact angle), enabled the control of drug loaded/released amounts (by the application of several consecutive processing cycles) and permitted the preparation of hydrophobic drug-based therapeutic SCLs in much shorter process times than those using conventional aqueous-based molecular imprinting methods.
本工作旨在开发一种创新的超临界流体(SCF)辅助分子印迹方法,以使商业软接触镜(SCL)能够负载特定药物并控制其释放。这种方法旨在克服常见的 SCL 负载方法的局限性,即通过浸入浓药物溶液中进行预成型 SCL 的负载(仅适用于高度水溶性药物),以及需要在聚合前选择药物的分子印迹方法的局限性,从而创建药物定制网络。特别是,我们专注于通过使用顺序 SCF 氟比洛芬浸渍和提取步骤来提高日常佩戴 Hilafilcon B 商业 SCL 的氟比洛芬负载/释放能力。在 12.0 MPa 和 40°C 下进行超临界二氧化碳(scCO2)浸渍测定,而在 20.0 MPa 和 40°C 下进行 scCO2 提取。进行了常规的氟比洛芬在水溶液中的吸附和药物去除实验以进行比较。SCF 处理的 SCL 显示出在水溶液中对氟比洛芬的识别能力和更高的亲和力,而对结构相关的布洛芬和地塞米松的亲和力较低,这表明由物理(溶胀/塑化)和化学(网络中的羰基基团与药物中的 C-F 基团)相互作用驱动的分子印迹空穴的形成。用 scCO2 处理不会改变 SCL 的一些关键功能特性(玻璃化转变温度、透光率、氧气透过率、接触角),能够控制负载/释放的药物量(通过应用多个连续的处理循环),并允许在比使用传统基于水的分子印迹方法短得多的时间内制备基于疏水性药物的治疗性 SCL。